Primmune Therapeutics is developing an orally administered TLR7 agonist to stimulate innate immunity in cancer immunotherapy. Our goal is to improve the response rate of patients to current and future immunotherapy medicines.
Company Details
- Employees
- 10
- Founded
- -
- Address
- Jlabs San Diego, 3210 Merryfield Road, San Diego,ca 92121,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- primmunerx.com
- Keywords
- Representative jobs.
- HQ
- San Diego, CA
Primmune Therapeutics Questions
Primmune Therapeutics's website is primmunerx.com
Primmune Therapeutics's LinkedIn profile is https://www.linkedin.com/company/primmune-therapeutics
Primmune Therapeutics has
10 employees.
View email and phone details for 10
employees at Primmune Therapeutics.
Primmune Therapeutics's industry is
Biotechnology Research
Primmune Therapeutics's top competitors are
Cullgen Inc.,
Poseida Therapeutics, Inc.,
Cirsium Biosciences,
Anavo Therapeutics Bv,
858 Therapeutics,
Equillium, Inc.,
Evince Biosciences,
Spica Therapeutics,
Superluminal Medicines Inc.,
Synox Therapeutics.
Primmune Therapeutics's categories are Biotechnology Research
Primmune Therapeutics's founding year is 2017
